Damora Therapeutics (DMRA) Return on Assets (2020 - 2026)

Damora Therapeutics (DMRA) has 7 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, down 1.0% from the prior year.
• Return on Assets for Q1 2026 stood at 0.01%, up from 0.02% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q2 2025 and bottomed at 0.02% in Q4 2025.
• The 5-year median for Return on Assets is 0.01% (2022), against an average of 0.01%.
• The widest annual swing landed in 2022, when Return on Assets changed 0 bps; it then slipped 1 bps in 2025.
• A 5-year view of Return on Assets shows it stood at 0.01% in 2022, then dropped by 12 bps to 0.01% in 2023, then surged by 43 bps to 0.0% in 2024, then tumbled by 205 bps to 0.02% in 2025, then soared by 62 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.02% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison